Altimmune Inc ALT Q1 2026 Earnings EPS Beat Surprises to the Upside Amid Pipeline Progress Enveric Biosciences Inc ENVB Q4 2024 Earnings Massive EPS Miss Highlights Ongoing Cash Burn and No Revenue REX Q3 2001 Earnings EPS Beats Estimates by 23 as Company Delivers Strong Quarter CBK Q1 2026 Earnings Earnings Beat Despite Stock Decline VLGEA Q1 2025 Earnings Profitability Holds Steady Amidst Challenging Retail Environment UiPath Q1 2026 Earnings Earnings Beat Driven by Cost Discipline Stock Rises